Evolent Health Inc. is a leading healthcare technology and services company that partners with healthcare organizations to improve their clinical and financial performance. By providing innovative solutions, including data-driven insights, care management tools, and population health strategies, Evolent Health helps organizations transition to value-based care models. Their integrated approach aims to enhance patient outcomes, optimize resource utilization, and empower healthcare providers through streamlined operations and advanced analytics. The company focuses on transforming the healthcare landscape by enabling more effective delivery of healthcare services and fostering better health experiences for patients.
Humana Inc. (NYSE: HUM) and Evolent Health, Inc. (NYSE: EVH) announced they have expanded their strategic medical oncology partnership to modernize and streamline prior authorization processes to include radiation and surgical oncology services. By connecting all primary approaches to treating cancer, this collaboration will help expedite approval of prior authorization requests, improve patient access to care, and ensure timely access to critical treatments.
Faith leaders from more than 80 Black churches in Chicago met on September 29, 2022, to discuss mental health stigma and learn how to better minister to mental health concerns among their congregants. The forum, which also featured local leaders in health care, community activism, and government, was held to educate and empower the attending faith leaders to open up conversations about mental health with congregants on Oct. 9 in honor of World Mental Health Day.
Shares of Evolent Health Inc Class A (NYSE:EVH) traded at a new 52-week high today of $39.78. So far today approximately 156,000 shares have been exchanged, as compared to an average 30-day volume of 1.3 million shares.
Evolent Health Inc Class A (NYSE:EVH) traded today at a new 52-week high of $39.59. This new high was reached on below average trading volume as 130,000 shares traded hands, while the average 30-day volume is approximately 1.3 million shares.
San Diego, CA -- (SBWIRE) -- 05/06/2021 -- A lawsuit is pending for certain investors in Evolent Health, Inc. (NYSE: EVH) shares over alleged securities laws violations and NYSE: EVH investors should contact the Shareholders Foundation.
